HomePress ReleasesNews
06 April 2017

MD Medical Group Announcement of the Extraordinary General Meeting

md_medical_group_announcement_of_the_extraordinary_general_meeting.pdf Download file (277 K)

MD Medical Group Investments Plc (“MD Medical Group”, “MDMG” or the “Company” – LSE: MDMG), a leading Russian private healthcare provider, announces that at a meeting on April 5th, 2017 the Board of Directors of MD Medical Group Investments Plc called an Extraordinary General Meeting of shareholders to be held at Lapino hospital, Lapino 111, Odintsovskiy district, Moscow Region, Russian Federation on April 28, 2017 at 11 a.m. local time, to consider and, if thought fit, pass the following resolutions which will be proposed to be passed in accordance with section 59A of the Companies Law Cap. 113 (as amended):-

1. THAT the issue of up to 8 417 000 ordinary shares of US$0,08 each in the Company be and is hereby approved and that the Company’s board of directors be and is hereby authorised to allot and issue up to 8,417,000 ordinary shares of US$0.08 each in the Company to such persons as the board of directors may, in its sole and unfettered discretion, determine, it being understood that the authority granted by this resolution shall lapse on 27 April 2022 and the issue price in respect of the aforesaid issue of shares shall be determined in accordance with procedure defined in the Directors’ Report (Appendix 1), a copy of which has been provided to the shareholders.

2. THAT the shareholders of the Company having considered the Directors’ Report (Appendix 1) dated 05 April, 2017 hereby irrevocably and unconditionally waive any pre-emptive and other rights they have or may have by operation of law and/or pursuant to the articles of association of the Company and/or otherwise in connection with the authority conferred on the board of directors for the issue and allotment of 8,417,000 ordinary shares of US$0.08 referred to in resolution no. 1 above.

appendix1.pdf Appendix 1

This release contains insider information.

For further information please contact:

Elena Romanova
MD Medical Group Investments Plc
Tel: +7 495 331 4120

Tom Blackwell: +7 919 102 9064
Sergii Pershyn: +1 929 855 8188

About MD Medical Group

MD Medical Group operates in the highly attractive Russian private healthcare service market and has a leading position in high-quality women's health and paediatrics. The company manages 32 modern healthcare facilities, including 4 hospitals and 28 outpatient clinics in Moscow and Moscow region, St. Petersburg, Ufa, Perm, Samara and Samara region, Irkutsk, Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Kostroma, Novokuznetsk, Krasnoyarsk, Omsk, Barnaul, and Vladimir.

The Company’s shares have been listed on the London Stock Exchange (LSE ticker “MDMG”) in the form of Global Depositary Receipts (GDRs) since 12 October 2012.

Forward-Looking Statements:

This press release contains forward looking statements, which are based on the Company’s current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company’s ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.

No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.

2018   2017   2016   2015   2014   2013   2012  
First Name*
Last Name*
Institution Name

© 2018 «Mother and child»

Developed by